The report provides a detailed analysis essential for establishing a Donepezil production plant. It encompasses all critical aspects necessary for Donepezil production, including the cost of Donepezil production, Donepezil plant cost, Donepezil production costs, and the overall Donepezil production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Donepezil production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Donepezil is known to improve thinking and memory related problems in individuals having Alzheimer's disease. It works by restricting the degradation of acetylcholine, a brain chemical important for learning and remembering things. Donepezil restricts certain enzymes that in turn results into improved levels of acetylcholine. It is useful in handling dementia linked to Alzheimer's disease by recovering amnesia and confusion.
Donepezil is also employed to relieve cognitive decline in patients having vascular dementia and Lewy body dementia. Although, it doesn't treat Alzheimer's disease completely but can offer significant help in managing cognitive function and overall life quality of these patients. It is available in various formulations like oral tablets and transdermal patches that allow its pliable use.
The market for Donepezil is driven by several key factors. Its use as a medication for the treatment of symptoms associated with Alzheimer's disease tends to increase its demand. Its mechanism that leads to the enhancement of acetylcholine, which improves various symptoms of dementia, makes it a popular drug. It is using in easing of cognitive decline in patients with vascular dementia and Lewy body dementia.
It is available in different formulations like oral tablets, disintegrating tablets, and transdermic patches, allowing for its flexible use. Developments in its demand because of it being an effective medication for Alzheimer's disease, it being cost-effective, and its ease of use due to flexible formulations, along with its cost-effectiveness as a generic medication, along with its production prices, market prices, and logistics directly influence industrial Donepezil procurement in the market across the globe.
Raw Material for Donepezil Production
According to the Donepezil production plant project report, the key raw materials used in the production of Donepezil include Ethyl Isonipecotate-Benzyl Chloride-Triethylamine-Toluene- Vitride-Oxalyl Chloride-Dimethyl Sulfoxide.
Production Process of Donepezil
The extensive Donepezil production cost report consists of the following major industrial production process:
- From Ethyl Isonipecotate, Benzyl Chloride, Triethylamine, Toluene, Vitride, Oxalyl Chloride and Dimethyl Sulfoxide: The production process of Donepezil involves several key steps. First, ethyl Isonipecotate is reacted with benzyl chloride in toluene and using triethylamine as a base, forming an intermediate compound. This intermediate compound is then reduced using Vitride. The compound obtained from reduction is further reacted with oxalyl chloride and dimethyl sulfoxide. Following it, triethylamine and water are added to assist the reaction, which forms Donepezil. The final product is purified using crystallization and drying.
Donepezil appears as a white to off-white solid powder. Its IUPAC name is 2-[(1-benzylpiperidin-4-yl) methyl]-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one. Its molecular formula is C24H29NO3, and its molecular weight is 379.49 g/mol. It has a melting point of 207°C and a probable boiling point of around 527.9°C. It has low solubility in water, and it is slightly soluble in acetone and chloroform. It is stored in dry environment for storing that helps it to retain its stability. Its physical and chemical properties, such as its solubility in water and other solvents, melting point, and crystalline structure, make it useful in pharmaceutical applications, mainly for treating Alzheimer's patients.